Cargando…

Neutralizing Antibody Fails to Impact the Course of Ebola Virus Infection in Monkeys

Prophylaxis with high doses of neutralizing antibody typically offers protection against challenge with viruses producing acute infections. In this study, we have investigated the ability of the neutralizing human monoclonal antibody, KZ52, to protect against Ebola virus in rhesus macaques. This ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oswald, Wendelien B, Geisbert, Thomas W, Davis, Kelly J, Geisbert, Joan B, Sullivan, Nancy J, Jahrling, Peter B, Parren, Paul W. H. I, Burton, Dennis R
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779296/ https://www.ncbi.nlm.nih.gov/pubmed/17238286 http://dx.doi.org/10.1371/journal.ppat.0030009

Ejemplares similares

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates
por: Sullivan, Nancy J., et al.
Publicado: (2003)

Evaluation in Nonhuman Primates of Vaccines against Ebola Virus
por: Geisbert, Thomas W., et al.
Publicado: (2002)

The Pathology of Experimental Aerosolized Monkeypox Virus Infection in Cynomolgus Monkeys (Macaca fascicularis)
por: Zaucha, Gary M, et al.
Publicado: (2001)

Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus
por: Mire, Chad E., et al.
Publicado: (2016)

Marburg and Ebola Hemorrhagic Fevers (Filoviruses)
por: Geisbert, Thomas W.
Publicado: (2015)

Immune Protection of Nonhuman Primates against Ebola Virus with Single Low-Dose Adenovirus Vectors Encoding Modified GPs
por: Sullivan, Nancy J, et al.
Publicado: (2006)

Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates
por: Geisbert, Thomas W., et al.
Publicado: (2008)

Current state of Ebola virus vaccines: A snapshot
por: Woolsey, Courtney, et al.
Publicado: (2021)

Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman Primates
por: Mire, Chad E., et al.
Publicado: (2016)

Crimean-Congo hemorrhagic fever virus strains Hoti and Afghanistan cause viremia and mild clinical disease in cynomolgus monkeys
por: Cross, Robert W., et al.
Publicado: (2020)

An Intranasal Exposure Model of Lethal Nipah Virus Infection in African Green Monkeys
por: Geisbert, Joan B, et al.
Publicado: (2020)

Effective Post-Exposure Treatment of Ebola Infection
por: Feldmann, Heinz, et al.
Publicado: (2007)

Transcriptome Analysis of Circulating Immune Cell Subsets Highlight the Role of Monocytes in Zaire Ebola Virus Makona Pathogenesis
por: Menicucci, Andrea R., et al.
Publicado: (2017)

Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants
por: Versteeg, Krista, et al.
Publicado: (2017)

Natural history of nonhuman primates after conjunctival exposure to Ebola virus
por: Cross, Robert W., et al.
Publicado: (2023)

Establishment of an African green monkey model for COVID-19
por: Woolsey, Courtney, et al.
Publicado: (2020)

Author Correction: Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants
por: Versteeg, Krista, et al.
Publicado: (2019)

Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase
por: Cross, Robert W, et al.
Publicado: (2020)

Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase
por: Cross, Robert W., et al.
Publicado: (2020)

Establishment of an African green monkey model for COVID-19 and protection against reinfection
por: Woolsey, Courtney, et al.
Publicado: (2020)

Single dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus
por: Mire, Chad E., et al.
Publicado: (2015)

Lipid nanoparticle siRNA treatment of Ebola virus Makona infected nonhuman primates
por: Thi, Emily P., et al.
Publicado: (2015)

Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses
por: Lehrer, Axel T., et al.
Publicado: (2021)

Vesicular Stomatitis Virus–Based Vaccines against Lassa and Ebola Viruses
por: Marzi, Andrea, et al.
Publicado: (2015)

Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study
por: Geisbert, Thomas W, et al.
Publicado: (2010)

The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever
por: Rubins, Kathleen H, et al.
Publicado: (2007)

Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms
por: Shedlock, Devon J., et al.
Publicado: (2010)

The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species of Ebolavirus
por: Cross, Robert W., et al.
Publicado: (2016)

Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirus
por: Mire, Chad E., et al.
Publicado: (2013)

Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus
por: Matassov, Demetrius, et al.
Publicado: (2015)

Deep Sequencing Identifies Noncanonical Editing of Ebola and Marburg Virus RNAs in Infected Cells
por: Shabman, Reed S., et al.
Publicado: (2014)

Potential Impact of a 2-Person Security Rule on BioSafety Level 4 Laboratory Workers
por: LeDuc, James W., et al.
Publicado: (2009)

Interferon-β 1a and SARS Coronavirus Replication
por: Hensley, Lisa E., et al.
Publicado: (2004)

Postexposure Treatment of Marburg Virus Infection
por: Geisbert, Thomas W., et al.
Publicado: (2010)

Safety of Recombinant VSV–Ebola Virus Vaccine Vector in Pigs
por: de Wit, Emmie, et al.
Publicado: (2015)

Kikwit Ebola Virus Disease Progression in the Rhesus Monkey Animal Model
por: Bennett, Richard S., et al.
Publicado: (2020)

Lipid Raft Microdomains: A Gateway for Compartmentalized Trafficking of Ebola and Marburg Viruses
por: Bavari, Sina, et al.
Publicado: (2002)

Protection Against Lethal Marburg Virus Infection Mediated by Lipid Encapsulated Small Interfering RNA
por: Ursic-Bedoya, Raul, et al.
Publicado: (2014)

Marburg and Ravn Viruses Fail to Cause Disease in the Domestic Ferret (Mustela putorius furo)
por: Cross, Robert W, et al.
Publicado: (2018)

Framework for Leadership and Training of Biosafety Level 4 Laboratory Workers
por: Le Duc, James W., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_f8gsl9422t61nn6kh82je3s60s